Raymond James & Associates Insulet Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

A detailed history of Raymond James & Associates transactions in Insulet Corp stock. As of the latest transaction made, Raymond James & Associates holds 37,456 shares of PODD stock, worth $9.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,456
Previous 36,089 3.79%
Holding current value
$9.98 Million
Previous $7.28 Million 19.71%
% of portfolio
0.01%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$180.69 - $239.01 $247,003 - $326,726
1,367 Added 3.79%
37,456 $8.72 Million
Q2 2024

Jul 19, 2024
SELL
$161.02 - $206.98 $507,374 - $652,193
-3,151 Reduced 8.03%
36,089 $7.28 Million
Q1 2024

Apr 22, 2024
SELL
$163.6 - $209.11 $1.71 Million - $2.19 Million
-10,460 Reduced 21.05%
39,240 $6.73 Million
Q4 2023

Jan 16, 2024
SELL
$127.77 - $221.42 $832,421 - $1.44 Million
-6,515 Reduced 11.59%
49,700 $10.8 Million
Q3 2023

Oct 24, 2023
BUY
$154.67 - $290.89 $315,681 - $593,706
2,041 Added 3.77%
56,215 $8.97 Million
Q2 2023

Jul 25, 2023
SELL
$272.48 - $330.23 $1.19 Million - $1.44 Million
-4,372 Reduced 7.47%
54,174 $15.6 Million
Q1 2023

Apr 14, 2023
BUY
$276.36 - $326.03 $388,285 - $458,072
1,405 Added 2.46%
58,546 $18.7 Million
Q4 2022

Feb 08, 2023
SELL
$212.22 - $313.46 $59,209 - $87,455
-279 Reduced 0.49%
57,141 $16.8 Million
Q3 2022

Oct 25, 2022
SELL
$224.6 - $281.45 $518,601 - $649,868
-2,309 Reduced 3.87%
57,420 $13.2 Million
Q2 2022

Aug 12, 2022
BUY
$186.4 - $279.02 $588,651 - $881,145
3,158 Added 5.58%
59,729 $13 Million
Q1 2022

May 11, 2022
BUY
$194.8 - $275.7 $3.91 Million - $5.54 Million
20,097 Added 55.1%
56,571 $15.1 Million
Q4 2021

Feb 08, 2022
BUY
$255.32 - $318.29 $3.19 Million - $3.97 Million
12,488 Added 52.06%
36,474 $9.71 Million
Q3 2021

Nov 02, 2021
SELL
$260.36 - $307.27 $905,532 - $1.07 Million
-3,478 Reduced 12.66%
23,986 $6.82 Million
Q2 2021

Aug 11, 2021
BUY
$225.52 - $304.06 $886,970 - $1.2 Million
3,933 Added 16.71%
27,464 $7.54 Million
Q1 2021

May 14, 2021
SELL
$235.95 - $293.05 $344,958 - $428,439
-1,462 Reduced 5.85%
23,531 $6.14 Million
Q4 2020

Feb 12, 2021
SELL
$215.97 - $265.89 $2.15 Million - $2.65 Million
-9,966 Reduced 28.51%
24,993 $6.39 Million
Q3 2020

Nov 04, 2020
SELL
$192.55 - $236.59 $154,617 - $189,981
-803 Reduced 2.25%
34,959 $8.27 Million
Q2 2020

Jul 28, 2020
BUY
$159.17 - $224.73 $50,297 - $71,014
316 Added 0.89%
35,762 $6.95 Million
Q1 2020

Apr 21, 2020
BUY
$130.01 - $216.44 $770,439 - $1.28 Million
5,926 Added 20.07%
35,446 $5.87 Million
Q4 2019

Feb 12, 2020
BUY
$144.81 - $186.0 $1.05 Million - $1.35 Million
7,282 Added 32.75%
29,520 $5.05 Million
Q3 2019

Nov 07, 2019
BUY
$117.35 - $167.95 $760,310 - $1.09 Million
6,479 Added 41.11%
22,238 $3.67 Million
Q2 2019

Aug 06, 2019
SELL
$82.13 - $120.73 $28,909 - $42,496
-352 Reduced 2.18%
15,759 $1.88 Million
Q1 2019

May 06, 2019
BUY
$72.44 - $101.87 $609,727 - $857,439
8,417 Added 109.4%
16,111 $1.53 Million
Q4 2018

Feb 11, 2019
SELL
$73.27 - $105.19 $20,075 - $28,822
-274 Reduced 3.44%
7,694 $610,000
Q3 2018

Nov 14, 2018
SELL
$81.43 - $108.13 $2.41 Million - $3.21 Million
-29,654 Reduced 78.82%
7,968 $844,000
Q2 2018

Aug 14, 2018
BUY
$83.27 - $101.93 $2.62 Million - $3.21 Million
31,479 Added 512.44%
37,622 $3.22 Million
Q1 2018

May 14, 2018
BUY
$68.49 - $87.2 $420,734 - $535,669
6,143 New
6,143 $532,000

Others Institutions Holding PODD

# of Institutions
687
Shares Held
62.6M
Call Options Held
640K
Put Options Held
881K
View Full List

About INSULET CORP

PODD Quotes by TradingView
  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email